当前位置: X-MOL 学术Am. J. Physiol. Renal Physiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
PF-06869206 is a selective inhibitor of renal Pi transport: evidence from in vitro and in vivo studies.
American Journal of Physiology-Renal Physiology ( IF 4.2 ) Pub Date : 2020-08-03 , DOI: 10.1152/ajprenal.00146.2020
Linto Thomas 1 , Jianxiang Xue 1 , Viktor N Tomilin 2 , Oleh M Pochynyuk 2 , Jessica A Dominguez Rieg 1 , Timo Rieg 1
Affiliation  

Plasma phosphate (Pi) levels are tightly controlled, and elevated plasma Pi levels are associated with an increased risk of cardiovascular complications and death. Two renal transport proteins mediate the majority of Pi reabsorption, the Na+-phosphate cotransporters Npt2a and Npt2c, with Npt2a accounting for 70-80% of Pi reabsorption. The aim of this study was to determine the in vitro effects of a novel Npt2a inhibitor (Npt2a-I, PF-06869206) in opossum kidney (OK) cells as well as determine its selectivity in vivo in Npt2a knockout (Npt2a-/-) mice. In OK cells, Npt2a-I caused dose-dependent reductions of Na+-dependent Pi uptake (IC50: ~1.4 μmol/L), while the unselective Npt2 inhibitor phosphonoformic acid (PFA) resulted in a ~20% stronger inhibition of Pi uptake. The dose-dependent inhibitory effects were present after 24-hour incubation with both low and high Pi media. Michaelis-Menten kinetics in OK cells identified a ~2.4-fold higher Km for Pi in response to Npt2a inhibition with no significant change in apparent Vmax. Higher PTH concentrations decreased Pi uptake equivalent to the maximal inhibitory effect of Npt2a-I. In vivo, the Npt2a-I induced a dose-dependent increase in urinary Pi excretion in wild-type mice (ED50: ~23 mg/kg), which was completely absent in Npt2a-/- mice, alongside a lack of decrease in plasma Pi. Of note, the Npt2a-I-induced dose-dependent increase in urinary Na+ excretion was still present in Npt2a-/- mice, a response possibly mediated by an off-target acute inhibitory effect of the Npt2a-I on open probability of the epithelial Na+ channel, ENaC, in the cortical collecting duct.

中文翻译:

PF-06869206 是一种选择性肾磷转运抑制剂:来自体外和体内研究的证据。

血浆磷酸盐 (P i ) 水平受到严格控制,血浆 P i水平升高与心血管并发症和死亡风险增加有关。两种肾转运蛋白介导了大部分的 P i重吸收,即 Na + -磷酸盐协同转运蛋白 Npt2a 和 Npt2c,其中 Npt2a 占 P i重吸收的70-80% 。本研究的目的是确定一种新型 Npt2a 抑制剂(Npt2a-I,PF-06869206)在负鼠肾 (OK) 细胞中的体外作用,并确定其在 Npt2a 敲除 (Npt2a -/- )中的体内选择性老鼠。在 OK 细胞中,Npt2a-I 引起 Na +依赖性 P i 的剂量依赖性降低摄取 (IC 50 : ~1.4 μmol/L),而非选择性 Npt2 抑制剂膦甲酸 (PFA) 对 P i摄取的抑制作用更强~20% 。与低和高 P i培养基孵育 24 小时后出现剂量依赖性抑制作用。OK 细胞中的 Michaelis-Menten 动力学确定了 P i 的K m高约 2.4 倍,以响应 Npt2a 抑制,而表观 V max没有显着变化。较高的 PTH 浓度降低了 P i摄取,相当于 Npt2a-I 的最大抑制作用。在体内,Npt2a-I 诱导野生型小鼠尿 P i排泄的剂量依赖性增加(ED 50: ~23 mg/kg),在 Npt2a -/-小鼠中完全不存在,同时血浆 P i没有减少。值得注意的是,Npt2a-I 诱导的尿 Na +排泄的剂量依赖性增加仍然存在于 Npt2a -/-小鼠中,这种反应可能是由 Npt2a-I 对开放概率的脱靶急性抑制作用介导的。皮层集合管中的上皮 Na +通道 ENaC。
更新日期:2020-08-20
down
wechat
bug